Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 14, 2003
End-stage renal disease: endocrine aspects of treatmentGudmundur Johannsson, Jarl AhlménJournal of Nephrology|May 28, 2003
Lipids, blood pressure and bone metabolism after growth hormone therapy in elderly hemodialysis patientsUnni Viidas, Gudmundur Johannsson, Lena Mattson-Hultén, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 16, 2005
Update on adverse drug events associated with parenteral ironGlenn M Chertow, Phillip D Mason, Odd Vaage-Nilsen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 20, 2004
On the relative safety of parenteral iron formulationsGlenn M Chertow, Phillip D Mason, Odd Vaage-Nilsen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patientsHans Furuland, Torbjörn Linde, Jarl Ahlmén, et al.Hemodialysis International. International Symposium on Home Hemodialysis|April 9, 2008
A new safety device for hemodialysisJarl Ahlmén, Karl-Henrik Gydell, Henrik Hadimeri, et al.Transplantation|July 17, 2004
Impaired kidney graft survival is associated with the TNF-alpha genotypeLars G Wramner, Jonny Norrby, Mirjana Hahn-Zoric, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 14, 2009
Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solutionLars Weiss, Bernd Stegmayr, Gudrun Malmsten, et al.Pageof 1